Spinal V2b neurons reveal a role for ipsilateral inhibition in speed control

  1. Rebecca A Callahan
  2. Richard Roberts
  3. Mohini Sengupta
  4. Yukiko Kimura
  5. Shin-ichi Higashijima
  6. Martha W Bagnall  Is a corresponding author
  1. Washington University School of Medicine, United States
  2. National Institute for Basic Biology, Japan

Abstract

The spinal cord contains a diverse array of interneurons that govern motor output. Traditionally, models of spinal circuits have emphasized the role of inhibition in enforcing reciprocal alternation between left and right sides or flexors and extensors. However, recent work has shown that inhibition also increases coincident with excitation during contraction. Here, using larval zebrafish, we investigate the V2b (Gata3+) class of neurons, which contribute to flexor-extensor alternation but are otherwise poorly understood. Using newly generated transgenic lines we define two stable subclasses with distinct neurotransmitter and morphological properties. These V2b subclasses synapse directly onto motor neurons with differential targeting to speed-specific circuits. In vivo, optogenetic manipulation of V2b activity modulates locomotor frequency: suppressing V2b neurons elicits faster locomotion, whereas activating V2b neurons slows locomotion. We conclude that V2b neurons serve as a brake on axial motor circuits. Together, these results indicate a role for ipsilateral inhibition in speed control.

Data availability

Datasets have been deposited on Dryad, https://dx.doi.org/10.5061/dryad.1d78mt2

The following data sets were generated

Article and author information

Author details

  1. Rebecca A Callahan

    Department of Neuroscience, Washington University School of Medicine, St Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Richard Roberts

    Department of Neuroscience, Washington University School of Medicine, St Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Mohini Sengupta

    Department of Neuroscience, Washington University School of Medicine, St Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Yukiko Kimura

    Division of Behavioral Neurobiology, National Institute for Basic Biology, Okazaki, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8381-8622
  5. Shin-ichi Higashijima

    Division of Behavioral Neurobiology, National Institute for Basic Biology, Okazaki, Japan
    Competing interests
    The authors declare that no competing interests exist.
  6. Martha W Bagnall

    Department of Neuroscience, Washington University School of Medicine, St Louis, United States
    For correspondence
    bagnall@wustl.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2102-6165

Funding

National BioResource Project

  • Shin-ichi Higashijima

National Institute on Deafness and Other Communication Disorders (R00 DC012536)

  • Martha W Bagnall

National Institute on Deafness and Other Communication Disorders (R01 DC016413)

  • Martha W Bagnall

National Institute of Neurological Disorders and Stroke (F32 NS103247)

  • Rebecca A Callahan

Alfred P. Sloan Foundation

  • Martha W Bagnall

Pew Charitable Trusts

  • Martha W Bagnall

McKnight Endowment Fund for Neuroscience

  • Martha W Bagnall

Children's Discovery Institute

  • Martha W Bagnall

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This research adheres to recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and received approval by the Washington University Institutional Animal Care and Use Committee (protocol 20170228).

Copyright

© 2019, Callahan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,509
    views
  • 379
    downloads
  • 40
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Rebecca A Callahan
  2. Richard Roberts
  3. Mohini Sengupta
  4. Yukiko Kimura
  5. Shin-ichi Higashijima
  6. Martha W Bagnall
(2019)
Spinal V2b neurons reveal a role for ipsilateral inhibition in speed control
eLife 8:e47837.
https://doi.org/10.7554/eLife.47837

Share this article

https://doi.org/10.7554/eLife.47837

Further reading

    1. Neuroscience
    David Richter, Dirk van Moorselaar, Jan Theeuwes
    Research Article

    Avoiding distraction by salient yet irrelevant stimuli is critical when accomplishing daily tasks. One possible mechanism to accomplish this is by suppressing stimuli that may be distracting such that they no longer compete for attention. While the behavioral benefits of distractor suppression are well established, its neural underpinnings are not yet fully understood. In a functional MRI (fMRI) study, we examined whether and how sensory responses in early visual areas show signs of distractor suppression after incidental learning of spatial statistical regularities. Participants were exposed to an additional singleton task where, unbeknownst to them, one location more frequently contained a salient distractor. We analyzed whether visual responses in terms of fMRI BOLD were modulated by this distractor predictability. Our findings indicate that implicit spatial priors shape sensory processing even at the earliest stages of cortical visual processing, evident in early visual cortex as a suppression of stimuli at locations which frequently contained distracting information. Notably, while this suppression was spatially (receptive field) specific, it did extend to nearby neutral locations and occurred regardless of whether distractors, nontarget items, or targets were presented at this location, suggesting that suppression arises before stimulus identification. Crucially, we observed similar spatially specific neural suppression even if search was only anticipated, but no search display was presented. Our results highlight proactive modulations in early visual cortex, where potential distractions are suppressed preemptively, before stimulus onset, based on learned expectations. Combined, our study underscores how the brain leverages implicitly learned prior knowledge to optimize sensory processing and attention allocation.

    1. Immunology and Inflammation
    2. Neuroscience
    Rocio Vicario, Stamatina Fragkogianni ... Frédéric Geissmann
    Research Article

    Somatic genetic heterogeneity resulting from post-zygotic DNA mutations is widespread in human tissues and can cause diseases, however, few studies have investigated its role in neurodegenerative processes such as Alzheimer’s disease (AD). Here, we report the selective enrichment of microglia clones carrying pathogenic variants, that are not present in neuronal, glia/stromal cells, or blood, from patients with AD in comparison to age-matched controls. Notably, microglia-specific AD-associated variants preferentially target the MAPK pathway, including recurrent CBL ring-domain mutations. These variants activate ERK and drive a microglia transcriptional program characterized by a strong neuro-inflammatory response, both in vitro and in patients. Although the natural history of AD-associated microglial clones is difficult to establish in humans, microglial expression of a MAPK pathway activating variant was previously shown to cause neurodegeneration in mice, suggesting that AD-associated neuroinflammatory microglial clones may contribute to the neurodegenerative process in patients.